# Carlsmed, Inc.: filings

CARL · Nasdaq · CIK 1794546 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/carl.md) · [Financials](/companies/carl/financials.md) · [Filings](/companies/carl/filings.md) · [Insiders](/companies/carl/insiders.md)

## Reports and events: 19 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 24, 3 14, 8-K 11, CORRESP 5, 10-Q 4, 144 4, D 4, S-8 3, SCHEDULE 13G 3, D/A 2, DRSLTR 2, EFFECT 2, UPLOAD 2, 10-K 1, 424B4 1, 4/A 1, 8-A12B 1, ARS 1, CERT 1, DEF 14A 1, DEFA14A 1, DRS 1, DRS/A 1, S-1 1, S-1/A 1, S-3 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-30 | 09:15 ET | [8-K](/filings/0001794546-26-000020.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001794546-26-000020 |
| 2026-09-08 | 16:06 ET | [8-K](/filings/0001794546-26-000018.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001794546-26-000018 |
| 2026-08-05 | 16:10 ET | [10-Q](/filings/0001794546-26-000016.md) | Quarterly report, period 2026-06-30 | 0001794546-26-000016 |
| 2026-08-05 | 16:05 ET | [8-K](/filings/0001794546-26-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001794546-26-000015 |
| 2026-06-03 | 16:05 ET | [8-K](/filings/0001193125-26-255404.md) | 5.07 Shareholder vote results | 0001193125-26-255404 |
| 2026-05-05 | 16:10 ET | [10-Q](/filings/0001794546-26-000011.md) | Quarterly report, period 2026-03-31 | 0001794546-26-000011 |
| 2026-05-05 | 16:05 ET | [8-K](/filings/0001794546-26-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001794546-26-000010 |
| 2026-04-22 | 08:30 ET | [DEF 14A](/filings/0001794546-26-000005.md) | Proxy statement, period 2026-06-03 | 0001794546-26-000005 |
| 2026-02-25 | 16:09 ET | [10-K](/filings/0001193125-26-071551.md) | Annual report, period 2025-12-31 | 0001193125-26-071551 |
| 2026-02-25 | 16:05 ET | [8-K](/filings/0001193125-26-071512.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-071512 |
| 2026-01-12 | 08:09 ET | [8-K](/filings/0001193125-26-009828.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-009828 |
| 2025-11-06 | 16:13 ET | [10-Q](/filings/0001193125-25-269545.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269545 |
| 2025-11-06 | 16:06 ET | [8-K](/filings/0001193125-25-269469.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269469 |
| 2025-10-30 | 16:07 ET | [8-K](/filings/0001193125-25-258525.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-258525 |
| 2025-08-28 | 16:10 ET | [10-Q](/filings/0000950170-25-111953.md) | Quarterly report, period 2025-06-30 | 0000950170-25-111953 |
| 2025-08-28 | 16:06 ET | [8-K](/filings/0000950170-25-111947.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-111947 |
| 2025-07-24 | 16:05 ET | [8-K](/filings/0000950170-25-098327.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-098327 |
| 2025-07-15 | 06:39 ET | [S-1/A](/filings/0000950170-25-095710.md) | Registration statement, amended | 0000950170-25-095710 |
| 2025-06-26 | 11:30 ET | [S-1](/filings/0000950123-25-006117.md) | Registration statement | 0000950123-25-006117 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 09:38 ET. No prices; not investment advice.